# Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function

> **NCT06761131** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Thrombocytopaenia
- Impaired Renal Function

## Interventions

- **DRUG:** Linezolid (LZD)

## Key facts

- **NCT ID:** NCT06761131
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-20
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-06-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06761131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06761131, "Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06761131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*